Title: | Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study |
Journal: | Cancer Epidemiol Biomarkers Prev |
Published: | 1 Jun 2020 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/32179703/ |
DOI: | https://doi.org/10.1158/1055-9965.EPI-19-1623 |
Title: | Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study |
Journal: | Cancer Epidemiol Biomarkers Prev |
Published: | 1 Jun 2020 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/32179703/ |
DOI: | https://doi.org/10.1158/1055-9965.EPI-19-1623 |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
The study found that diabetes was associated with increased risk of cancers of the stomach, liver, bladder, endometrium, and lung among smokers, and with decreased risk of prostate cancer. Compared with the normal HbA1c category, the increased risk category was positively associated with risk of cancers of the colon, liver, bladder, and lung among smokers, and the high-risk category was associated with increased risk of cancers of the esophagus, liver, pancreas, and bladder, and with decreased risk of prostate cancer. Based on the study results the authors suggested that both diabetes and/or elevated HbA1c are associated with risk of cancer at several anatomic sites.
Application ID | Title |
---|---|
40086 | The association of type 2 diabetes and HbA1c with subsequent risk of cancer at different anatomical sites |
Enabling scientific discoveries that improve human health